Bombus terrestris chromosome 13, iyBomTerr1.2, whole genome shotgun sequence.
Bombus terrestris (buff-tailed bumblebee)
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Hymenoptera; Apocrita; Aculeata; Apoidea; Apidae; Bombus; Bombus.
REFSEQ INFORMATION: The reference sequence is identical to\nOU342933.1.\nAssembly name: iyBomTerr1.2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2022/02/09. The original whole-genome shotgun project has the\naccession CAJUYY000000000.2.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Bombus terrestris Annotation Release\n 103\nAnnotation Version :: 103\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
COORDINATES: polyA evidence [ECO:0006239]
uncharacterized LOC125386175, transcript variant X2
uncharacterized LOC125386175, transcript variant X1
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 57% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125386172, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC125386172, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC125386172, transcript variant X3
uncharacterized LOC125386172, transcript variant X5
uncharacterized LOC125386172, transcript variant X1
uncharacterized LOC125386172, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC125386172, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC125386241, transcript variant X2
uncharacterized LOC125386241, transcript variant X1
uncharacterized LOC125386241, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
uncharacterized LOC125386241, transcript variant X4
signal recognition particle receptor subunit beta
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC125386170, transcript variant X4
uncharacterized LOC125386170, transcript variant X5
uncharacterized LOC125386170, transcript variant X2
uncharacterized LOC125386170, transcript variant X7
uncharacterized LOC125386170, transcript variant X1
uncharacterized LOC125386170, transcript variant X3
uncharacterized LOC125386170, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC125386170, transcript variant X8
uncharacterized protein LOC125386170 isoform X4
uncharacterized protein LOC125386170 isoform X1
uncharacterized protein LOC125386170 isoform X3
uncharacterized protein LOC125386170 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125386161, transcript variant X1
uncharacterized LOC125386161, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uncharacterized LOC125386183, transcript variant X2
uncharacterized LOC125386183, transcript variant X1
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA isoleucine (anticodon AAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
EF-hand calcium-binding domain-containing protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
transcription factor HES-1, transcript variant X2
transcription factor HES-1, transcript variant X1
POU domain, class 6, transcription factor 1, transcript variant X3
POU domain, class 6, transcription factor 1, transcript variant X1
POU domain, class 6, transcription factor 1, transcript variant X2
POU domain, class 6, transcription factor 1 isoform X1
POU domain, class 6, transcription factor 1 isoform X3
POU domain, class 6, transcription factor 1 isoform X2
uncharacterized LOC100649920, transcript variant X1
uncharacterized protein LOC100649920 isoform X1
uncharacterized LOC100649920, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
uncharacterized protein LOC100649920 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 21% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC100649804, transcript variant X4
uncharacterized LOC100649804, transcript variant X1
uncharacterized LOC100649804, transcript variant X3
uncharacterized LOC100649804, transcript variant X2
glucose dehydrogenase [FAD, quinone], transcript variant X7
glucose dehydrogenase [FAD, quinone], transcript variant X10
glucose dehydrogenase [FAD, quinone], transcript variant X4
glucose dehydrogenase [FAD, quinone], transcript variant X13
glucose dehydrogenase [FAD, quinone], transcript variant X11
glucose dehydrogenase [FAD, quinone], transcript variant X5
glucose dehydrogenase [FAD, quinone], transcript variant X2
glucose dehydrogenase [FAD, quinone], transcript variant X12
glucose dehydrogenase [FAD, quinone], transcript variant X6
glucose dehydrogenase [FAD, quinone], transcript variant X3
glucose dehydrogenase [FAD, quinone], transcript variant X8
glucose dehydrogenase [FAD, quinone], transcript variant X1
glucose dehydrogenase [FAD, quinone], transcript variant X9
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125386164, transcript variant X2
uncharacterized LOC125386164, transcript variant X6
uncharacterized LOC125386164, transcript variant X4
uncharacterized LOC125386164, transcript variant X3
uncharacterized LOC125386164, transcript variant X1
uncharacterized LOC125386164, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
uncharacterized LOC100649166, transcript variant X2
uncharacterized protein LOC100649166 isoform X2
uncharacterized LOC100649166, transcript variant X1
uncharacterized protein LOC100649166 isoform X1
endocuticle structural glycoprotein ABD-4
putative fatty acyl-CoA reductase CG5065
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 90% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC100648592, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC100648592, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC100648592, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC100648592, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 85 samples with support for all annotated introns
uncharacterized protein LOC100648592 isoform X2
uncharacterized protein LOC100648592 isoform X1
uncharacterized protein LOC100648592 isoform X3
endocuticle structural glycoprotein SgAbd-1
endocuticle structural glycoprotein SgAbd-2-like
cytochrome P450 302a1, mitochondrial, transcript variant X2
cytochrome P450 302a1, mitochondrial, transcript variant X3
cytochrome P450 302a1, mitochondrial, transcript variant X1
cytochrome P450 302a1, mitochondrial isoform X1
cytochrome P450 302a1, mitochondrial isoform X2
retinol dehydrogenase 12, transcript variant X2
retinol dehydrogenase 12, transcript variant X1
retinol dehydrogenase 12, transcript variant X3
retinol dehydrogenase 12, transcript variant X4
retinol dehydrogenase 12, transcript variant X5
uncharacterized LOC100650658, transcript variant X2
uncharacterized LOC100650658, transcript variant X1
COP9 signalosome complex subunit 7b, transcript variant X1
COP9 signalosome complex subunit 7b isoform X1
COP9 signalosome complex subunit 7b, transcript variant X3
COP9 signalosome complex subunit 7b, transcript variant X2
COP9 signalosome complex subunit 7 isoform X3
COP9 signalosome complex subunit 7b isoform X2
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2
paired amphipathic helix protein Sin3a, transcript variant X2
paired amphipathic helix protein Sin3a, transcript variant X1
paired amphipathic helix protein Sin3a isoform X2
paired amphipathic helix protein Sin3a isoform X1
mitochondrial tRNA-specific 2-thiouridylase 1, transcript variant X4
mitochondrial tRNA-specific 2-thiouridylase 1, transcript variant X3
mitochondrial tRNA-specific 2-thiouridylase 1, transcript variant X1
mitochondrial tRNA-specific 2-thiouridylase 1, transcript variant X5
mitochondrial tRNA-specific 2-thiouridylase 1, transcript variant X7
mitochondrial tRNA-specific 2-thiouridylase 1, transcript variant X6
mitochondrial tRNA-specific 2-thiouridylase 1, transcript variant X2
mitochondrial tRNA-specific 2-thiouridylase 1 isoform X1
mitochondrial tRNA-specific 2-thiouridylase 1 isoform X2
mitochondrial tRNA-specific 2-thiouridylase 1 isoform X3
segment polarity protein dishevelled homolog DVL-3, transcript variant X1
segment polarity protein dishevelled homolog DVL-3, transcript variant X6
segment polarity protein dishevelled homolog DVL-3, transcript variant X3
segment polarity protein dishevelled homolog DVL-3, transcript variant X2
segment polarity protein dishevelled homolog DVL-3, transcript variant X5
segment polarity protein dishevelled homolog DVL-3, transcript variant X7
segment polarity protein dishevelled homolog DVL-3, transcript variant X4
segment polarity protein dishevelled homolog DVL-3, transcript variant X8
segment polarity protein dishevelled homolog DVL-3 isoform X4
segment polarity protein dishevelled homolog DVL-3 isoform X2
segment polarity protein dishevelled homolog DVL-3 isoform X3
segment polarity protein dishevelled homolog DVL-3 isoform X1
uncharacterized LOC105666387, transcript variant X10
uncharacterized LOC105666387, transcript variant X9
uncharacterized LOC105666387, transcript variant X1
uncharacterized LOC105666387, transcript variant X6
uncharacterized LOC105666387, transcript variant X3
uncharacterized LOC105666387, transcript variant X4
uncharacterized LOC105666387, transcript variant X12
uncharacterized LOC105666387, transcript variant X2
uncharacterized LOC105666387, transcript variant X8
uncharacterized LOC105666387, transcript variant X11
uncharacterized LOC105666387, transcript variant X5
uncharacterized LOC105666387, transcript variant X7
structural maintenance of chromosomes protein 5, transcript variant X2
structural maintenance of chromosomes protein 5, transcript variant X1
structural maintenance of chromosomes protein 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 39% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 57% coverage of the annotated genomic feature by RNAseq alignments
receptor-type guanylate cyclase gcy-3, transcript variant X2
receptor-type guanylate cyclase gcy-3, transcript variant X4
receptor-type guanylate cyclase gcy-3, transcript variant X3
receptor-type guanylate cyclase gcy-3, transcript variant X1
receptor-type guanylate cyclase gcy-3 isoform X1
receptor-type guanylate cyclase gcy-3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
EGF domain-specific O-linked N-acetylglucosamine transferase, transcript variant X1
EGF domain-specific O-linked N-acetylglucosamine transferase, transcript variant X2
EGF domain-specific O-linked N-acetylglucosamine transferase isoform X1
EGF domain-specific O-linked N-acetylglucosamine transferase isoform X2
phosphatidylinositol-glycan biosynthesis class W protein
39S ribosomal protein L10, mitochondrial
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: 39S ribosomal protein L10, mitochondrial
UBX domain-containing protein 4, transcript variant X2
UBX domain-containing protein 4, transcript variant X3
UBX domain-containing protein 4, transcript variant X1
UBX domain-containing protein 4 isoform X1
UBX domain-containing protein 4 isoform X2
UBX domain-containing protein 4 isoform X3
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 151 samples with support for all annotated introns
uncharacterized LOC105666383, transcript variant X2
uncharacterized LOC105666383, transcript variant X3
uncharacterized LOC105666383, transcript variant X4
uncharacterized LOC105666383, transcript variant X5
uncharacterized LOC105666383, transcript variant X6
uncharacterized LOC105666383, transcript variant X10
uncharacterized LOC105666383, transcript variant X1
uncharacterized LOC105666383, transcript variant X11
uncharacterized LOC105666383, transcript variant X12
uncharacterized LOC105666383, transcript variant X8
uncharacterized LOC105666383, transcript variant X7
uncharacterized LOC105666383, transcript variant X9
homeotic protein distal-less, transcript variant X2
homeotic protein distal-less, transcript variant X1
homeotic protein distal-less, transcript variant X4
homeotic protein distal-less, transcript variant X3
homeotic protein distal-less, transcript variant X6
homeotic protein distal-less, transcript variant X5
homeotic protein distal-less, transcript variant X7
glutamate decarboxylase, transcript variant X2
glutamate decarboxylase, transcript variant X1
fumarylacetoacetase, transcript variant X1
fumarylacetoacetase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
coiled-coil domain-containing protein 113
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 22% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 80% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC100645889, transcript variant X2
uncharacterized LOC100645889, transcript variant X3
uncharacterized LOC100645889, transcript variant X1
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X1
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X2
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X3
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X4
voltage-dependent L-type calcium channel subunit beta-2 isoform X1
voltage-dependent L-type calcium channel subunit beta-2 isoform X4
voltage-dependent L-type calcium channel subunit beta-2 isoform X3
voltage-dependent L-type calcium channel subunit beta-2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
putative sodium-dependent multivitamin transporter
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 ESTs, 50 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
carboxypeptidase B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
carboxypeptidase B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
piezo-type mechanosensitive ion channel component, transcript variant X1
piezo-type mechanosensitive ion channel component, transcript variant X5
piezo-type mechanosensitive ion channel component, transcript variant X8
piezo-type mechanosensitive ion channel component, transcript variant X10
piezo-type mechanosensitive ion channel component, transcript variant X4
piezo-type mechanosensitive ion channel component, transcript variant X2
piezo-type mechanosensitive ion channel component, transcript variant X3
piezo-type mechanosensitive ion channel component, transcript variant X6
piezo-type mechanosensitive ion channel component, transcript variant X7
piezo-type mechanosensitive ion channel component, transcript variant X9
piezo-type mechanosensitive ion channel component isoform X1
piezo-type mechanosensitive ion channel component isoform X5
piezo-type mechanosensitive ion channel component isoform X8
piezo-type mechanosensitive ion channel component isoform X10
piezo-type mechanosensitive ion channel component isoform X4
piezo-type mechanosensitive ion channel component isoform X2
piezo-type mechanosensitive ion channel component isoform X3
piezo-type mechanosensitive ion channel component isoform X6
piezo-type mechanosensitive ion channel component isoform X7
piezo-type mechanosensitive ion channel component isoform X9
piezo-type mechanosensitive ion channel component, transcript variant X12
piezo-type mechanosensitive ion channel component, transcript variant X11
piezo-type mechanosensitive ion channel component isoform X11
uncharacterized LOC100643092, transcript variant X1
uncharacterized LOC100643092, transcript variant X3
uncharacterized protein LOC100643092 isoform X1
uncharacterized protein LOC100643092 isoform X3
uncharacterized LOC100643092, transcript variant X2
uncharacterized protein LOC100643092 isoform X2
carcinine transporter, transcript variant X1
carcinine transporter, transcript variant X2
probable nuclear hormone receptor HR38, transcript variant X3
probable nuclear hormone receptor HR38, transcript variant X2
probable nuclear hormone receptor HR38, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 134 samples with support for all annotated introns
probable nuclear hormone receptor HR38, transcript variant X6
probable nuclear hormone receptor HR38, transcript variant X5
probable nuclear hormone receptor HR38, transcript variant X4
probable nuclear hormone receptor HR38, transcript variant X7
nuclear receptor subfamily 4 group A member 2 isoform X6
nuclear receptor subfamily 4 group A member 2 isoform X5
nuclear receptor subfamily 4 group A member 2 isoform X4
probable nuclear hormone receptor HR38 isoform X7
ras-related protein rab-6.2, transcript variant X2
ras-related protein rab-6.2, transcript variant X1
cysteine desulfurase, mitochondrial, transcript variant X2
cysteine desulfurase, mitochondrial, transcript variant X1
cysteine desulfurase, mitochondrial isoform X2
cysteine desulfurase, mitochondrial isoform X1
fez family zinc finger protein 2, transcript variant X2
fez family zinc finger protein 2, transcript variant X1
fez family zinc finger protein 2 isoform X1
fez family zinc finger protein 2, transcript variant X3
fez family zinc finger protein 2 isoform X2
dual serine/threonine and tyrosine protein kinase, transcript variant X7
dual serine/threonine and tyrosine protein kinase, transcript variant X6
dual serine/threonine and tyrosine protein kinase isoform X3
dual serine/threonine and tyrosine protein kinase, transcript variant X5
dual serine/threonine and tyrosine protein kinase, transcript variant X1
dual serine/threonine and tyrosine protein kinase, transcript variant X3
dual serine/threonine and tyrosine protein kinase, transcript variant X2
dual serine/threonine and tyrosine protein kinase, transcript variant X4
dual serine/threonine and tyrosine protein kinase isoform X2
dual serine/threonine and tyrosine protein kinase isoform X1
forkhead box protein P1, transcript variant X4
forkhead box protein P1, transcript variant X12
forkhead box protein P1, transcript variant X1
forkhead box protein P1, transcript variant X2
forkhead box protein P1, transcript variant X10
forkhead box protein P1, transcript variant X3
forkhead box protein P1, transcript variant X5
forkhead box protein P1, transcript variant X6
forkhead box protein P1, transcript variant X7
forkhead box protein P1, transcript variant X9
forkhead box protein P1, transcript variant X8
forkhead box protein P1, transcript variant X11
forkhead box protein P1, transcript variant X13
forkhead box protein P1, transcript variant X14
forkhead box protein P1, transcript variant X16
forkhead box protein P1, transcript variant X15
protein tyrosine phosphatase domain-containing protein 1, transcript variant X2
protein tyrosine phosphatase domain-containing protein 1, transcript variant X1
protein tyrosine phosphatase domain-containing protein 1 isoform X1
protein tyrosine phosphatase domain-containing protein 1 isoform X2
secretory carrier-associated membrane protein 5A, transcript variant X23
secretory carrier-associated membrane protein 5A, transcript variant X2
secretory carrier-associated membrane protein 5A, transcript variant X4
secretory carrier-associated membrane protein 5A, transcript variant X3
secretory carrier-associated membrane protein 5A, transcript variant X5
secretory carrier-associated membrane protein 5A, transcript variant X1
secretory carrier-associated membrane protein 5A, transcript variant X8
secretory carrier-associated membrane protein 5A, transcript variant X7
secretory carrier-associated membrane protein 5A, transcript variant X9
secretory carrier-associated membrane protein 5A, transcript variant X10
secretory carrier-associated membrane protein 5A, transcript variant X11
secretory carrier-associated membrane protein 5A, transcript variant X12
secretory carrier-associated membrane protein 5A, transcript variant X18
secretory carrier-associated membrane protein 5A, transcript variant X6
secretory carrier-associated membrane protein 5A, transcript variant X13
secretory carrier-associated membrane protein 5A, transcript variant X16
secretory carrier-associated membrane protein 5A, transcript variant X21
secretory carrier-associated membrane protein 5A, transcript variant X17
secretory carrier-associated membrane protein 5A, transcript variant X15
secretory carrier-associated membrane protein 5A, transcript variant X14
secretory carrier-associated membrane protein 5A, transcript variant X20
secretory carrier-associated membrane protein 5A, transcript variant X22
secretory carrier-associated membrane protein 5A, transcript variant X19
secretory carrier-associated membrane protein 5A isoform X1
secretory carrier-associated membrane protein 5A isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC100649111, transcript variant X1
uncharacterized LOC100649111, transcript variant X2
uncharacterized protein LOC100649111 isoform X1
uncharacterized protein LOC100649111 isoform X2
basement membrane-specific heparan sulfate proteoglycan core protein, transcript variant X5
basement membrane-specific heparan sulfate proteoglycan core protein, transcript variant X6
basement membrane-specific heparan sulfate proteoglycan core protein, transcript variant X4
basement membrane-specific heparan sulfate proteoglycan core protein, transcript variant X2
basement membrane-specific heparan sulfate proteoglycan core protein, transcript variant X3
basement membrane-specific heparan sulfate proteoglycan core protein, transcript variant X8
basement membrane-specific heparan sulfate proteoglycan core protein, transcript variant X1
basement membrane-specific heparan sulfate proteoglycan core protein, transcript variant X9
basement membrane-specific heparan sulfate proteoglycan core protein, transcript variant X7
basement membrane-specific heparan sulfate proteoglycan core protein, transcript variant X10
basement membrane-specific heparan sulfate proteoglycan core protein isoform X2
basement membrane-specific heparan sulfate proteoglycan core protein isoform X1
basement membrane-specific heparan sulfate proteoglycan core protein isoform X3
uncharacterized LOC100647158, transcript variant X1
uncharacterized LOC100647158, transcript variant X2
uncharacterized LOC100647158, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
ankyrin repeat and death domain-containing protein 1A, transcript variant X1
ankyrin repeat and death domain-containing protein 1A, transcript variant X2
ankyrin repeat and death domain-containing protein 1A isoform X1
ankyrin repeat and death domain-containing protein 1A isoform X2
heterogeneous nuclear ribonucleoprotein 27C, transcript variant X3
heterogeneous nuclear ribonucleoprotein 27C isoform X3
heterogeneous nuclear ribonucleoprotein 27C, transcript variant X5
heterogeneous nuclear ribonucleoprotein 27C isoform X5
heterogeneous nuclear ribonucleoprotein 27C, transcript variant X6
heterogeneous nuclear ribonucleoprotein 27C, transcript variant X1
heterogeneous nuclear ribonucleoprotein 27C isoform X6
heterogeneous nuclear ribonucleoprotein 27C isoform X1
heterogeneous nuclear ribonucleoprotein 27C, transcript variant X2
heterogeneous nuclear ribonucleoprotein 27C isoform X2
heterogeneous nuclear ribonucleoprotein 27C, transcript variant X4
heterogeneous nuclear ribonucleoprotein 27C isoform X4
chondroitin sulfate synthase 1, transcript variant X2
chondroitin sulfate synthase 1, transcript variant X1
chondroitin sulfate synthase 1, transcript variant X3
chondroitin sulfate synthase 1, transcript variant X4
immediate early response 3-interacting protein 1
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase-like, transcript variant X2
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase-like, transcript variant X1
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase-like isoform X1
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase-like isoform X2
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase-like, transcript variant X3
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase-like isoform X3
uncharacterized LOC125386203, transcript variant X1
uncharacterized LOC125386203, transcript variant X2
uncharacterized LOC125386202, transcript variant X1
uncharacterized LOC125386202, transcript variant X2
neuropeptide CCHamide-1 receptor, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
neuropeptide CCHamide-1 receptor, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
neuropeptide CCHamide-1 receptor, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 121 samples with support for all annotated introns
neuropeptide CCHamide-1 receptor, transcript variant X1
neuropeptide CCHamide-1 receptor, transcript variant X5
neuropeptide CCHamide-1 receptor, transcript variant X4
neuropeptide CCHamide-1 receptor, transcript variant X2
neuropeptide CCHamide-1 receptor, transcript variant X3
neprilysin-1-like, transcript variant X2
neprilysin-1-like, transcript variant X1
5-hydroxytryptamine receptor, transcript variant X4
5-hydroxytryptamine receptor, transcript variant X3
5-hydroxytryptamine receptor, transcript variant X1
5-hydroxytryptamine receptor, transcript variant X2
5-hydroxytryptamine receptor, transcript variant X5
5-hydroxytryptamine receptor, transcript variant X7
5-hydroxytryptamine receptor, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
RING finger protein nhl-1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
RING finger protein nhl-1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 116 samples with support for all annotated introns
RING finger protein nhl-1, transcript variant X5
RING finger protein nhl-1, transcript variant X6
RING finger protein nhl-1, transcript variant X8
RING finger protein nhl-1, transcript variant X7
RING finger protein nhl-1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 68 samples with support for all annotated introns
RING finger protein nhl-1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 94 samples with support for all annotated introns
serine-rich adhesin for platelets isoform X1
serine-rich adhesin for platelets isoform X2
calmodulin-binding transcription activator 2, transcript variant X5
calmodulin-binding transcription activator 2, transcript variant X3
calmodulin-binding transcription activator 2, transcript variant X1
calmodulin-binding transcription activator 2, transcript variant X4
calmodulin-binding transcription activator 2, transcript variant X2
calmodulin-binding transcription activator 2, transcript variant X6
calmodulin-binding transcription activator 2 isoform X4
calmodulin-binding transcription activator 2 isoform X2
calmodulin-binding transcription activator 2 isoform X1
calmodulin-binding transcription activator 2 isoform X5
calmodulin-binding transcription activator 2 isoform X3
AP-2 complex subunit mu, transcript variant X1
AP-2 complex subunit mu, transcript variant X2
CTD nuclear envelope phosphatase 1 homolog, transcript variant X4
CTD nuclear envelope phosphatase 1 homolog, transcript variant X3
CTD nuclear envelope phosphatase 1 homolog, transcript variant X2
CTD nuclear envelope phosphatase 1 homolog, transcript variant X1
CTD nuclear envelope phosphatase 1 homolog, transcript variant X5
CTD nuclear envelope phosphatase 1 homolog isoform X4
CTD nuclear envelope phosphatase 1 homolog isoform X3
CTD nuclear envelope phosphatase 1 homolog isoform X2
CTD nuclear envelope phosphatase 1 homolog isoform X1
BMP and activin membrane-bound inhibitor homolog
biogenesis of lysosome-related organelles complex 1 subunit 1, transcript variant X3
biogenesis of lysosome-related organelles complex 1 subunit 1, transcript variant X2
biogenesis of lysosome-related organelles complex 1 subunit 1, transcript variant X1
biogenesis of lysosome-related organelles complex 1 subunit 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 67% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 38% coverage of the annotated genomic feature by RNAseq alignments
probable pre-mRNA-splicing factor ATP-dependent RNA helicase mog-4
F-box/LRR-repeat protein 2, transcript variant X2
F-box/LRR-repeat protein 2, transcript variant X1
F-box/LRR-repeat protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
chitin-binding domain protein cbd-1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
serine proteinase stubble, transcript variant X2
serine proteinase stubble, transcript variant X1
serine protease filzig, transcript variant X1
serine protease filzig, transcript variant X2
unconventional myosin-Va, transcript variant X2
unconventional myosin-Va, transcript variant X4
unconventional myosin-Va, transcript variant X6
unconventional myosin-Va, transcript variant X3
unconventional myosin-Va, transcript variant X1
unconventional myosin-Va, transcript variant X7
unconventional myosin-Va, transcript variant X5
DC-STAMP domain-containing protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
calponin homology domain-containing protein DDB_G0272472-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
succinate dehydrogenase assembly factor 3, mitochondrial, transcript variant X2
succinate dehydrogenase assembly factor 3, mitochondrial, transcript variant X1
succinate dehydrogenase assembly factor 3, mitochondrial
acyl-coenzyme A diphosphatase NUDT19, transcript variant X1
acyl-coenzyme A diphosphatase NUDT19, transcript variant X2
acyl-coenzyme A diphosphatase NUDT19 isoform X1
acyl-coenzyme A diphosphatase NUDT19 isoform X2
L-threonine 3-dehydrogenase, mitochondrial, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
L-threonine 3-dehydrogenase, mitochondrial, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 95 samples with support for all annotated introns
L-threonine 3-dehydrogenase, mitochondrial isoform X2
L-threonine 3-dehydrogenase, mitochondrial isoform X1
26S proteasome non-ATPase regulatory subunit 7
inosine triphosphate pyrophosphatase, transcript variant X1
inosine triphosphate pyrophosphatase, transcript variant X2
vitellogenin-like; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001331111.1
annotated by transcript or proteomic data
The RefSeq transcript has 8 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to AA sequence (same species):RefSeq:NP_001318040.1
The RefSeq protein has 3 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
COORDINATES: ab initio prediction:SignalP:4.0
transfer RNA asparagine (anticodon GUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transcription factor Sox-2, transcript variant X1
transcription factor Sox-2, transcript variant X3
transcription factor Sox-2, transcript variant X13
transcription factor Sox-2, transcript variant X18
transcription factor Sox-2, transcript variant X12
transcription factor Sox-2, transcript variant X9
transcription factor Sox-2, transcript variant X17
transcription factor Sox-2, transcript variant X16
transcription factor Sox-2, transcript variant X11
transcription factor Sox-2, transcript variant X7
transcription factor Sox-2, transcript variant X15
transcription factor Sox-2, transcript variant X5
transcription factor Sox-2, transcript variant X4
transcription factor Sox-2, transcript variant X2
transcription factor Sox-2, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
transcription factor Sox-2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 101 samples with support for all annotated introns
transcription factor Sox-2, transcript variant X6
transcription factor Sox-2, transcript variant X14
uncharacterized LOC100642898, transcript variant X1
uncharacterized LOC100642898, transcript variant X2
uncharacterized protein LOC100642898 isoform X2
uncharacterized protein LOC100642898 isoform X1
serine/arginine repetitive matrix protein 2, transcript variant X2
serine/arginine repetitive matrix protein 2, transcript variant X1
serine/arginine repetitive matrix protein 2, transcript variant X3
serine/arginine repetitive matrix protein 2 isoform X2
serine/arginine repetitive matrix protein 2 isoform X1
serine/arginine repetitive matrix protein 2 isoform X3
mannose-P-dolichol utilization defect 1 protein homolog
tubulin glycylase 3A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
tubulin glycylase 3A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
tubulin glycylase 3A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
UPF0430 protein CG31712, transcript variant X3
UPF0430 protein CG31712, transcript variant X4
UPF0430 protein CG31712, transcript variant X1
UPF0430 protein CG31712, transcript variant X2
serine/threonine-protein kinase 25, transcript variant X8
serine/threonine-protein kinase 25 isoform X6
serine/threonine-protein kinase 25, transcript variant X6
serine/threonine-protein kinase 25 isoform X4
serine/threonine-protein kinase 25, transcript variant X3
serine/threonine-protein kinase 25, transcript variant X4
serine/threonine-protein kinase 25 isoform X2
serine/threonine-protein kinase 25, transcript variant X1
serine/threonine-protein kinase 25, transcript variant X2
serine/threonine-protein kinase 25, transcript variant X7
serine/threonine-protein kinase 25 isoform X5
serine/threonine-protein kinase 25 isoform X1
serine/threonine-protein kinase 25, transcript variant X5
serine/threonine-protein kinase 25 isoform X3
uncharacterized LOC100651932, transcript variant X2
uncharacterized LOC100651932, transcript variant X1
uncharacterized LOC100651932, transcript variant X3
LHFPL tetraspan subfamily member 2 protein, transcript variant X3
LHFPL tetraspan subfamily member 2 protein, transcript variant X1
LHFPL tetraspan subfamily member 2 protein, transcript variant X2
LHFPL tetraspan subfamily member 2 protein
putative gamma-glutamylcyclotransferase CG2811, transcript variant X1
putative gamma-glutamylcyclotransferase CG2811, transcript variant X2
putative gamma-glutamylcyclotransferase CG2811 isoform X2
putative gamma-glutamylcyclotransferase CG2811 isoform X1
putative gamma-glutamylcyclotransferase CG2811, transcript variant X3
putative gamma-glutamylcyclotransferase CG2811 isoform X3
pyruvate dehydrogenase (acetyl-transferring) kinase, mitochondrial, transcript variant X1
pyruvate dehydrogenase (acetyl-transferring) kinase, mitochondrial, transcript variant X2
pyruvate dehydrogenase (acetyl-transferring) kinase, mitochondrial, transcript variant X3
pyruvate dehydrogenase (acetyl-transferring) kinase, mitochondrial isoform X3
pyruvate dehydrogenase (acetyl-transferring) kinase, mitochondrial isoform X1
pyruvate dehydrogenase (acetyl-transferring) kinase, mitochondrial isoform X2
uncharacterized protein LOC100651098 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 69 samples with support for all annotated introns
translation machinery-associated protein 7 homolog, transcript variant X1
translation machinery-associated protein 7 homolog, transcript variant X2
translation machinery-associated protein 7 homolog
cyclin-dependent kinase 4, transcript variant X10
cyclin-dependent kinase 4, transcript variant X8
cyclin-dependent kinase 4, transcript variant X12
cyclin-dependent kinase 4, transcript variant X3
cyclin-dependent kinase 4, transcript variant X4
cyclin-dependent kinase 4, transcript variant X1
cyclin-dependent kinase 4, transcript variant X6
cyclin-dependent kinase 4, transcript variant X11
cyclin-dependent kinase 4, transcript variant X5
cyclin-dependent kinase 4, transcript variant X9
cyclin-dependent kinase 4, transcript variant X7
cyclin-dependent kinase 4, transcript variant X2
protein N-terminal glutamine amidohydrolase, transcript variant X4
protein N-terminal glutamine amidohydrolase, transcript variant X2
protein N-terminal glutamine amidohydrolase, transcript variant X6
protein N-terminal glutamine amidohydrolase, transcript variant X1
protein N-terminal glutamine amidohydrolase, transcript variant X5
protein N-terminal glutamine amidohydrolase, transcript variant X3
protein N-terminal glutamine amidohydrolase isoform X2
protein N-terminal glutamine amidohydrolase isoform X1
isochorismatase domain-containing protein 2
uncharacterized LOC100650700, transcript variant X2
uncharacterized LOC100650700, transcript variant X3
uncharacterized LOC100650700, transcript variant X1
uncharacterized protein LOC100650700 isoform X1
uncharacterized LOC100650700, transcript variant X4
uncharacterized protein LOC100650700 isoform X2
transcription factor CP2-like protein 1, transcript variant X3
transcription factor CP2-like protein 1, transcript variant X4
transcription factor CP2-like protein 1, transcript variant X2
transcription factor CP2-like protein 1, transcript variant X1
transcription factor CP2-like protein 1 isoform X3
transcription factor CP2-like protein 1 isoform X4
transcription factor CP2-like protein 1 isoform X2
transcription factor CP2-like protein 1 isoform X1
probable inactive tRNA-specific adenosine deaminase-like protein 3, transcript variant X5
probable inactive tRNA-specific adenosine deaminase-like protein 3, transcript variant X3
probable inactive tRNA-specific adenosine deaminase-like protein 3, transcript variant X1
probable inactive tRNA-specific adenosine deaminase-like protein 3, transcript variant X2
probable inactive tRNA-specific adenosine deaminase-like protein 3, transcript variant X4
probable inactive tRNA-specific adenosine deaminase-like protein 3 isoform X1
probable inactive tRNA-specific adenosine deaminase-like protein 3 isoform X2
receptor-type tyrosine-protein phosphatase delta
putative WEB family protein At1g65010, chloroplastic
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125386166, transcript variant X1
uncharacterized LOC125386166, transcript variant X2
cyclic AMP-dependent transcription factor ATF-2, transcript variant X3
cyclic AMP-dependent transcription factor ATF-2, transcript variant X2
cyclic AMP-dependent transcription factor ATF-2, transcript variant X1
cyclic AMP-dependent transcription factor ATF-2 isoform X2
cyclic AMP-dependent transcription factor ATF-2 isoform X1
39S ribosomal protein L16, mitochondrial
transmembrane protein 132C, transcript variant X1
transmembrane protein 132C, transcript variant X2
116 kDa U5 small nuclear ribonucleoprotein component
polycomb group protein Psc, transcript variant X1
polycomb group protein Psc, transcript variant X2
serine-rich adhesin for platelets, transcript variant X1
serine-rich adhesin for platelets, transcript variant X3
serine-rich adhesin for platelets, transcript variant X2
leucine-rich repeat-containing protein 51
peroxisomal targeting signal 1 receptor, transcript variant X2
peroxisomal targeting signal 1 receptor, transcript variant X1
beta-1,3-galactosyltransferase 1, transcript variant X2
beta-1,3-galactosyltransferase 1, transcript variant X1
beta-1,3-galactosyltransferase 1 isoform X2
beta-1,3-galactosyltransferase 1 isoform X1
AP-3 complex subunit sigma-2, transcript variant X2
AP-3 complex subunit sigma-2, transcript variant X1
GATA zinc finger domain-containing protein 1
uncharacterized LOC100651382, transcript variant X1
uncharacterized LOC100651382, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC100651382 isoform X2
uncharacterized protein LOC100651382 isoform X1
uncharacterized LOC105666405, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC105666405, transcript variant X3
uncharacterized LOC105666405, transcript variant X1
uncharacterized LOC105666405, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 66 samples with support for all annotated introns
broad-complex core protein isoforms 1/2/3/4/5, transcript variant X6
broad-complex core protein isoforms 1/2/3/4/5, transcript variant X4
broad-complex core protein isoforms 1/2/3/4/5, transcript variant X2
broad-complex core protein isoforms 1/2/3/4/5, transcript variant X1
broad-complex core protein isoforms 1/2/3/4/5, transcript variant X11
broad-complex core protein isoforms 1/2/3/4/5, transcript variant X13
broad-complex core protein isoforms 1/2/3/4/5, transcript variant X15
broad-complex core protein isoforms 1/2/3/4/5, transcript variant X9
broad-complex core protein isoforms 1/2/3/4/5, transcript variant X10
broad-complex core protein isoforms 1/2/3/4/5, transcript variant X12
broad-complex core protein isoforms 1/2/3/4/5, transcript variant X14
broad-complex core protein isoforms 1/2/3/4/5, transcript variant X7
broad-complex core protein isoforms 1/2/3/4/5, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 89 samples with support for all annotated introns
broad-complex core protein isoforms 1/2/3/4/5, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 88 samples with support for all annotated introns
broad-complex core protein isoforms 1/2/3/4/5, transcript variant X3
broad-complex core protein isoforms 1/2/3/4/5, transcript variant X5
broad-complex core protein isoforms 1/2/3/4/5, transcript variant X8
broad-complex core protein isoforms 1/2/3/4/5 isoform X3
broad-complex core protein isoforms 1/2/3/4/5 isoform X5
broad-complex core protein isoforms 1/2/3/4/5 isoform X7
broad-complex core protein isoforms 1/2/3/4/5 isoform X8
broad-complex core protein isoforms 1/2/3/4/5 isoform X4
broad-complex core protein isoforms 1/2/3/4/5 isoform X1
broad-complex core protein isoforms 1/2/3/4/5 isoform X2
endoplasmic reticulum resident protein 44, transcript variant X1
endoplasmic reticulum resident protein 44, transcript variant X2
endoplasmic reticulum resident protein 44 isoform X2
endoplasmic reticulum resident protein 44 isoform X1
obg-like ATPase 1, transcript variant X1
obg-like ATPase 1, transcript variant X2
potassium voltage-gated channel subfamily H member 8, transcript variant X1
potassium voltage-gated channel subfamily H member 8, transcript variant X2
potassium voltage-gated channel subfamily H member 8, transcript variant X3
potassium voltage-gated channel subfamily H member 8, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
potassium voltage-gated channel subfamily H member 8 isoform X1
potassium voltage-gated channel subfamily H member 8 isoform X2
potassium voltage-gated channel subfamily H member 8 isoform X3
potassium voltage-gated channel subfamily H member 8 isoform X5
potassium voltage-gated channel subfamily H member 8, transcript variant X4
potassium voltage-gated channel subfamily H member 8 isoform X4
mitochondrial 2-oxoglutarate/malate carrier protein
DNA repair protein REV1, transcript variant X1
DNA repair protein REV1, transcript variant X2
cytochrome b5 domain-containing protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 69% coverage of the annotated genomic feature by RNAseq alignments
malate dehydrogenase, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
serine/threonine-protein kinase 17B, transcript variant X1
serine/threonine-protein kinase 17B isoform X1
serine/threonine-protein kinase 17B, transcript variant X2
serine/threonine-protein kinase 17A isoform X2
probable serine/threonine-protein kinase MARK-A, transcript variant X1
probable serine/threonine-protein kinase MARK-A isoform X1
probable serine/threonine-protein kinase MARK-A, transcript variant X2
probable serine/threonine-protein kinase MARK-A isoform X2
ATP-dependent RNA helicase DDX42, transcript variant X1
ATP-dependent RNA helicase DDX42, transcript variant X2
cationic amino acid transporter 4, transcript variant X1
cationic amino acid transporter 4, transcript variant X3
cationic amino acid transporter 4, transcript variant X4
cationic amino acid transporter 4, transcript variant X2
acetyl-coenzyme A transporter 1, transcript variant X2
acetyl-coenzyme A transporter 1, transcript variant X1
acetyl-coenzyme A transporter 1 isoform X1
acetyl-coenzyme A transporter 1 isoform X2
host cell factor 2, transcript variant X2
uncharacterized LOC100644977, transcript variant X2
uncharacterized LOC100644977, transcript variant X1
host cell factor 2, transcript variant X1
host cell factor 2, transcript variant X3
uncharacterized protein LOC100644654 isoform X1
protein brunelleschi, transcript variant X2
protein brunelleschi, transcript variant X1
CKLF-like MARVEL transmembrane domain-containing protein 4, transcript variant X3
CKLF-like MARVEL transmembrane domain-containing protein 4 isoform X2
CKLF-like MARVEL transmembrane domain-containing protein 4, transcript variant X1
CKLF-like MARVEL transmembrane domain-containing protein 4, transcript variant X2
dynein axonemal intermediate chain 3 isoform X1
pyridoxine/pyridoxamine 5'-phosphate oxidase, transcript variant X1
pyridoxine/pyridoxamine 5'-phosphate oxidase, transcript variant X2
pyridoxine/pyridoxamine 5'-phosphate oxidase isoform X2
pyridoxine/pyridoxamine 5'-phosphate oxidase isoform X1
atrial natriuretic peptide-converting enzyme, transcript variant X1
atrial natriuretic peptide-converting enzyme, transcript variant X2
atrial natriuretic peptide-converting enzyme, transcript variant X5
atrial natriuretic peptide-converting enzyme, transcript variant X4
atrial natriuretic peptide-converting enzyme, transcript variant X3
atrial natriuretic peptide-converting enzyme isoform X1
atrial natriuretic peptide-converting enzyme isoform X3
atrial natriuretic peptide-converting enzyme isoform X2
armadillo segment polarity protein, transcript variant X1
armadillo segment polarity protein, transcript variant X2
armadillo segment polarity protein, transcript variant X4
armadillo segment polarity protein isoform X1
armadillo segment polarity protein, transcript variant X3
armadillo segment polarity protein isoform X2
zinc finger protein 845, transcript variant X1
zinc finger protein 845, transcript variant X2
uncharacterized LOC105666420, transcript variant X2
uncharacterized LOC105666420, transcript variant X1
U11/U12 small nuclear ribonucleoprotein 48 kDa protein, transcript variant X3
U11/U12 small nuclear ribonucleoprotein 48 kDa protein, transcript variant X1
U11/U12 small nuclear ribonucleoprotein 48 kDa protein, transcript variant X2
U11/U12 small nuclear ribonucleoprotein 48 kDa protein
serine/threonine-protein kinase fused, transcript variant X1
serine/threonine-protein kinase fused, transcript variant X2
serine/threonine-protein kinase fused isoform X1
serine/threonine-protein kinase fused isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cytochrome P450 306a1, transcript variant X1
cytochrome P450 306a1, transcript variant X3
cytochrome P450 306a1, transcript variant X4
cytochrome P450 306a1, transcript variant X2
cytochrome P450 18a1, transcript variant X2
cytochrome P450 18a1, transcript variant X1
glycolipid transfer protein, transcript variant X1
glycolipid transfer protein, transcript variant X2
26S proteasome non-ATPase regulatory subunit 11
serine proteinase stubble, transcript variant X3
serine proteinase stubble, transcript variant X5
serine proteinase stubble, transcript variant X4
uncharacterized protein LOC100652014 isoform X1
uncharacterized protein LOC100652014 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
ras-related protein RabJ, transcript variant X1
ras-related protein RabJ, transcript variant X2
LOW QUALITY PROTEIN: ornithine decarboxylase antizyme 1
myosin-2 essential light chain, transcript variant X2
myosin-2 essential light chain, transcript variant X3
myosin-2 essential light chain, transcript variant X1
myosin-2 essential light chain isoform X2
myosin-2 essential light chain isoform X1
myosin-2 essential light chain isoform X3
WD repeat, SAM and U-box domain-containing protein 1, transcript variant X3
WD repeat, SAM and U-box domain-containing protein 1, transcript variant X1
WD repeat, SAM and U-box domain-containing protein 1, transcript variant X4
WD repeat, SAM and U-box domain-containing protein 1, transcript variant X2
WD repeat, SAM and U-box domain-containing protein 1, transcript variant X7
WD repeat, SAM and U-box domain-containing protein 1, transcript variant X6
WD repeat, SAM and U-box domain-containing protein 1, transcript variant X5
WD repeat, SAM and U-box domain-containing protein 1 isoform X2
WD repeat, SAM and U-box domain-containing protein 1 isoform X1
WD repeat, SAM and U-box domain-containing protein 1 isoform X3
WD repeat, SAM and U-box domain-containing protein 1 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
sphingomyelin phosphodiesterase, transcript variant X6
sphingomyelin phosphodiesterase, transcript variant X5
sphingomyelin phosphodiesterase, transcript variant X1
sphingomyelin phosphodiesterase, transcript variant X3
sphingomyelin phosphodiesterase, transcript variant X4
sphingomyelin phosphodiesterase, transcript variant X8
sphingomyelin phosphodiesterase isoform X2
sphingomyelin phosphodiesterase isoform X3
sphingomyelin phosphodiesterase isoform X1
sphingomyelin phosphodiesterase, transcript variant X7
sphingomyelin phosphodiesterase, transcript variant X2
multiple coagulation factor deficiency protein 2 homolog, transcript variant X2
multiple coagulation factor deficiency protein 2 homolog, transcript variant X1
multiple coagulation factor deficiency protein 2 homolog, transcript variant X3
multiple coagulation factor deficiency protein 2 homolog, transcript variant X4
multiple coagulation factor deficiency protein 2 homolog, transcript variant X5
multiple coagulation factor deficiency protein 2 homolog
ribosomal oxygenase 1, transcript variant X2
ribosomal oxygenase 1, transcript variant X1
protein argonaute-2, transcript variant X1
protein argonaute-2, transcript variant X2
39S ribosomal protein L53, mitochondrial
proteasomal ubiquitin receptor ADRM1-A, transcript variant X2
proteasomal ubiquitin receptor ADRM1-A, transcript variant X1
proteasomal ubiquitin receptor ADRM1-A, transcript variant X3
proteasomal ubiquitin receptor ADRM1-A isoform X2
proteasomal ubiquitin receptor ADRM1 homolog isoform X3
proteasomal ubiquitin receptor ADRM1-A isoform X1
arrestin domain-containing protein 17, transcript variant X2
arrestin domain-containing protein 17, transcript variant X1
arrestin domain-containing protein 17, transcript variant X3
arrestin domain-containing protein 17 isoform X2
arrestin domain-containing protein 17 isoform X1
putative polypeptide N-acetylgalactosaminyltransferase 9, transcript variant X5
putative polypeptide N-acetylgalactosaminyltransferase 9, transcript variant X3
putative polypeptide N-acetylgalactosaminyltransferase 9, transcript variant X1
putative polypeptide N-acetylgalactosaminyltransferase 9, transcript variant X4
putative polypeptide N-acetylgalactosaminyltransferase 9, transcript variant X2
putative polypeptide N-acetylgalactosaminyltransferase 9 isoform X1
putative polypeptide N-acetylgalactosaminyltransferase 9 isoform X2
serine-enriched protein, transcript variant X3
serine-enriched protein, transcript variant X2
serine-enriched protein, transcript variant X1
golgin subfamily A member 6-like protein 6 isoform X1
golgin subfamily A member 6-like protein 6 isoform X2
uncharacterized LOC100649594, transcript variant X1
uncharacterized LOC100649594, transcript variant X2
uncharacterized LOC100649594, transcript variant X3
uncharacterized LOC100649594, transcript variant X4
uncharacterized protein LOC100649594 isoform X2
uncharacterized protein LOC100649594 isoform X1
uncharacterized protein LOC100649594 isoform X4
uncharacterized protein LOC100649594 isoform X3
PAN2-PAN3 deadenylation complex catalytic subunit PAN2
integrin alpha-PS2, transcript variant X2
integrin alpha-PS2, transcript variant X1
integrin alpha-PS2, transcript variant X10
integrin alpha-PS2, transcript variant X6
integrin alpha-PS2, transcript variant X9
integrin alpha-PS2, transcript variant X7
integrin alpha-PS2, transcript variant X5
integrin alpha-PS2, transcript variant X8
integrin alpha-PS2, transcript variant X3
integrin alpha-PS2, transcript variant X4
uncharacterized LOC100649390, transcript variant X3
uncharacterized LOC100649390, transcript variant X2
uncharacterized LOC100649390, transcript variant X1
NF-kappa-B essential modulator, transcript variant X2
NF-kappa-B essential modulator, transcript variant X4
NF-kappa-B essential modulator, transcript variant X1
NF-kappa-B essential modulator, transcript variant X3
NF-kappa-B essential modulator isoform X2
NF-kappa-B essential modulator isoform X1
uncharacterized LOC110119807, transcript variant X1
uncharacterized LOC110119807, transcript variant X3
uncharacterized LOC110119807, transcript variant X2
pyruvate carboxylase, mitochondrial, transcript variant X1
pyruvate carboxylase, mitochondrial, transcript variant X2
pyruvate carboxylase, mitochondrial isoform X1
pyruvate carboxylase, mitochondrial isoform X2
uncharacterized LOC100648338, transcript variant X5
uncharacterized LOC100648338, transcript variant X2
uncharacterized LOC100648338, transcript variant X4
uncharacterized LOC100648338, transcript variant X1
uncharacterized LOC100648338, transcript variant X7
uncharacterized LOC100648338, transcript variant X3
uncharacterized LOC125386223, transcript variant X2
uncharacterized LOC125386223, transcript variant X1
uncharacterized LOC100648338, transcript variant X6
uncharacterized protein LOC100648338 isoform X1
uncharacterized protein LOC100648338 isoform X2
bumetanide-sensitive sodium-(potassium)-chloride cotransporter, transcript variant X5
bumetanide-sensitive sodium-(potassium)-chloride cotransporter, transcript variant X2
bumetanide-sensitive sodium-(potassium)-chloride cotransporter, transcript variant X4
bumetanide-sensitive sodium-(potassium)-chloride cotransporter, transcript variant X3
bumetanide-sensitive sodium-(potassium)-chloride cotransporter, transcript variant X1
bumetanide-sensitive sodium-(potassium)-chloride cotransporter
ATP-dependent (S)-NAD(P)H-hydrate dehydratase, transcript variant X3
ATP-dependent (S)-NAD(P)H-hydrate dehydratase, transcript variant X2
ATP-dependent (S)-NAD(P)H-hydrate dehydratase, transcript variant X1
ATP-dependent (S)-NAD(P)H-hydrate dehydratase, transcript variant X4
ATP-dependent (S)-NAD(P)H-hydrate dehydratase isoform X1
ATP-dependent (S)-NAD(P)H-hydrate dehydratase isoform X2
probable cytochrome P450 6a14, transcript variant X2
probable cytochrome P450 6a14, transcript variant X1
cytochrome P450 6a2, transcript variant X1
cytochrome P450 6a2, transcript variant X2
probable cytochrome P450 6a13, transcript variant X2
probable cytochrome P450 6a13, transcript variant X1
PI-PLC X domain-containing protein 2, transcript variant X2
PI-PLC X domain-containing protein 2, transcript variant X1
PI-PLC X domain-containing protein 2, transcript variant X3
PI-PLC X domain-containing protein 3 isoform X1
PI-PLC X domain-containing protein 2 isoform X2
PAT complex subunit CCDC47, transcript variant X4
PAT complex subunit CCDC47, transcript variant X5
PAT complex subunit CCDC47, transcript variant X2
PAT complex subunit CCDC47, transcript variant X3
PAT complex subunit CCDC47, transcript variant X1
uncharacterized protein CG7065 isoform X1
potassium voltage-gated channel protein Shaw, transcript variant X1
potassium voltage-gated channel protein Shaw, transcript variant X3
potassium voltage-gated channel protein Shaw, transcript variant X2
potassium voltage-gated channel protein Shaw isoform X1
potassium voltage-gated channel protein Shaw isoform X3
potassium voltage-gated channel protein Shaw isoform X2
potassium voltage-gated channel protein Shaw-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
uncharacterized LOC100648997, transcript variant X1
uncharacterized LOC100648997, transcript variant X2
uncharacterized protein LOC100648997 isoform X1
uncharacterized protein LOC100648997 isoform X2
protein drumstick, transcript variant X1
protein drumstick, transcript variant X2
protein drumstick, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
insulin receptor substrate 1, transcript variant X1
insulin receptor substrate 1, transcript variant X4
insulin receptor substrate 1, transcript variant X2
insulin receptor substrate 1, transcript variant X3
insulin receptor substrate 1-B isoform X1
piwi-like protein Ago3, transcript variant X6
piwi-like protein Ago3, transcript variant X5
piwi-like protein Ago3, transcript variant X1
piwi-like protein Ago3, transcript variant X2
piwi-like protein Ago3, transcript variant X4
piwi-like protein Ago3, transcript variant X3
cGMP-dependent protein kinase foraging, transcript variant X1
cGMP-dependent protein kinase foraging, transcript variant X2
cGMP-dependent protein kinase foraging, transcript variant X3
cGMP-dependent protein kinase, isozyme 2 forms cD4/T1/T3A/T3B isoform X1
cGMP-dependent protein kinase, isozyme 2 forms cD4/T1/T3A/T3B isoform X2
cGMP-dependent protein kinase, isozyme 2 forms cD5/T2 isoform X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
microsomal triacylglycerol transfer protein, transcript variant X1
microsomal triacylglycerol transfer protein, transcript variant X2
microsomal triacylglycerol transfer protein isoform X1
microsomal triacylglycerol transfer protein isoform X2
vesicle transport through interaction with t-SNAREs homolog 1A, transcript variant X1
vesicle transport through interaction with t-SNAREs homolog 1A, transcript variant X2
vesicle transport through interaction with t-SNAREs homolog 1A, transcript variant X3
vesicle transport through interaction with t-SNAREs homolog 1A isoform X1
vesicle transport through interaction with t-SNAREs homolog 1A isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
G patch domain-containing protein 4, transcript variant X2
G patch domain-containing protein 4, transcript variant X1
G patch domain-containing protein 4, transcript variant X3
G patch domain-containing protein 4 isoform X1
putative histone-lysine N-methyltransferase 1 isoform X2
probable transcriptional regulatory protein Cthe_2075
uncharacterized LOC100647235, transcript variant X2
uncharacterized LOC100647235, transcript variant X1
uncharacterized protein LOC100647235 isoform X2
uncharacterized protein LOC100647235 isoform X1
cell wall integrity and stress response component 2
probable methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial, transcript variant X1
probable methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial, transcript variant X2
probable methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial isoform X1
probable methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial isoform X2
putative E3 ubiquitin-protein ligase UNKL, transcript variant X2
putative E3 ubiquitin-protein ligase UNKL, transcript variant X1
putative E3 ubiquitin-protein ligase UNKL, transcript variant X3
putative E3 ubiquitin-protein ligase UNKL, transcript variant X4
putative E3 ubiquitin-protein ligase UNKL isoform X2
putative E3 ubiquitin-protein ligase UNKL isoform X1
putative E3 ubiquitin-protein ligase UNKL isoform X3
uncharacterized LOC125386240, transcript variant X2
uncharacterized LOC125386240, transcript variant X3
uncharacterized LOC125386240, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
echinoderm microtubule-associated protein-like 2, transcript variant X7
echinoderm microtubule-associated protein-like 2, transcript variant X3
echinoderm microtubule-associated protein-like 2, transcript variant X4
echinoderm microtubule-associated protein-like 2, transcript variant X1
echinoderm microtubule-associated protein-like 2, transcript variant X2
echinoderm microtubule-associated protein-like 2, transcript variant X6
echinoderm microtubule-associated protein-like 2, transcript variant X9
echinoderm microtubule-associated protein-like 2, transcript variant X8
echinoderm microtubule-associated protein-like 2, transcript variant X11
echinoderm microtubule-associated protein-like 2, transcript variant X10
echinoderm microtubule-associated protein-like 2, transcript variant X5
echinoderm microtubule-associated protein-like 2 isoform X2
echinoderm microtubule-associated protein-like 2 isoform X8
echinoderm microtubule-associated protein-like 2 isoform X6
echinoderm microtubule-associated protein-like 2 isoform X7
echinoderm microtubule-associated protein-like 2 isoform X5
echinoderm microtubule-associated protein-like 2 isoform X3
echinoderm microtubule-associated protein-like 2 isoform X1
echinoderm microtubule-associated protein-like 2 isoform X4
transfer RNA serine (anticodon CGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
MD-2-related lipid-recognition protein, transcript variant X2
MD-2-related lipid-recognition protein, transcript variant X1
MD-2-related lipid-recognition protein isoform X2
MD-2-related lipid-recognition protein isoform X1
MAP7 domain-containing protein 2, transcript variant X5
MAP7 domain-containing protein 2, transcript variant X10
MAP7 domain-containing protein 2, transcript variant X4
MAP7 domain-containing protein 2, transcript variant X2
MAP7 domain-containing protein 2, transcript variant X3
MAP7 domain-containing protein 2, transcript variant X9
MAP7 domain-containing protein 2, transcript variant X6
MAP7 domain-containing protein 2, transcript variant X1
MAP7 domain-containing protein 2, transcript variant X8
uncharacterized protein LOC100648655 isoform X3
uncharacterized protein LOC100648655 isoform X2
uncharacterized protein LOC100648655 isoform X1
MAP7 domain-containing protein 2 isoform X5
MAP7 domain-containing protein 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
uncharacterized protein LOC100648655 isoform X4
breast cancer metastasis-suppressor 1-like protein, transcript variant X3
breast cancer metastasis-suppressor 1-like protein, transcript variant X1
breast cancer metastasis-suppressor 1-like protein, transcript variant X4
breast cancer metastasis-suppressor 1-like protein, transcript variant X2
breast cancer metastasis-suppressor 1-like protein
facilitated trehalose transporter Tret1, transcript variant X9
facilitated trehalose transporter Tret1, transcript variant X1
facilitated trehalose transporter Tret1, transcript variant X3
facilitated trehalose transporter Tret1, transcript variant X2
facilitated trehalose transporter Tret1, transcript variant X5
facilitated trehalose transporter Tret1, transcript variant X8
facilitated trehalose transporter Tret1, transcript variant X4
facilitated trehalose transporter Tret1, transcript variant X7
facilitated trehalose transporter Tret1, transcript variant X6
facilitated trehalose transporter Tret1-2 homolog isoform X1
facilitated trehalose transporter Tret1 isoform X2
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: peptidoglycan recognition protein 3
uncharacterized LOC105666395, transcript variant X1
uncharacterized LOC105666395, transcript variant X2
uncharacterized protein LOC105666395 isoform X1
uncharacterized protein LOC105666395 isoform X2
uncharacterized LOC100648414, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC100648414, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC100648414, transcript variant X4
uncharacterized LOC100648414, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC100648414, transcript variant X5
uncharacterized LOC100648414, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC100648414, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
GATOR complex protein Iml1, transcript variant X1
GATOR complex protein Iml1, transcript variant X2
GATOR complex protein Iml1, transcript variant X6
GATOR complex protein Iml1, transcript variant X5
GATOR complex protein Iml1, transcript variant X8
GATOR complex protein Iml1, transcript variant X12
GATOR complex protein Iml1, transcript variant X13
GATOR complex protein Iml1, transcript variant X11
GATOR complex protein Iml1, transcript variant X9
GATOR complex protein Iml1, transcript variant X10
GATOR complex protein Iml1, transcript variant X4
GATOR complex protein Iml1, transcript variant X7
GATOR complex protein Iml1, transcript variant X3
GATOR complex protein Iml1, transcript variant X14
rac GTPase-activating protein 1, transcript variant X2
rac GTPase-activating protein 1, transcript variant X1
DNA-directed RNA polymerases I, II, and III subunit RPABC4
F-box only protein 43, transcript variant X2
F-box only protein 43, transcript variant X3
F-box only protein 43, transcript variant X1
uncharacterized protein LOC100646633 isoform X3
uncharacterized protein LOC100646633 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
threonylcarbamoyladenosine tRNA methylthiotransferase
glucose dehydrogenase [FAD, quinone] isoform X1
glucose dehydrogenase [FAD, quinone] isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00026